RHJA
SGNT

Rice Hall James & Associates’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Rice Hall James & Associates’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-161,620
Closed -$2.42M – 313
2016
Q2 		$2.42M Buy
161,620
+57,790
+56% +$742K 0.14% 135
2016
Q1 		$1.26M Buy
103,830
+600
+0.6% +$8.41K 0.07% 229
2015
Q4 		$1.64M Buy
+103,230
New +$1.63M 0.09% 196

Rice Hall James & Associates's SGNT Position: Q3 2016 in Review

Rice Hall James & Associates sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 161,620 shares — an estimated $2.42M sold.

Rice Hall James & Associates first reported a position in SGNT in Q4 2015 and held it in 3 quarters. The position peaked at $2.42M in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Rice Hall James & Associates reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Rice Hall James & Associates sold 161,620 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $2.42M.
  • Rice Hall James & Associates first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2015 and held it in 3 quarters.
  • Rice Hall James & Associates's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $2.42M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Rice Hall James & Associates's 13F filing for Q3 2016, filed 20 Oct 2016.